Laparoscopic total mesorectal excision versus transanal total mesorectal excision for mid and low rectal cancer: A systematic review and meta-analysis
Zhang Yi Chi,Ou Gang,Feng Xiao Li,Lu Ya,Zhou Zhijun,Du Yong Gang,Ran Dan,Liu Xin,Liu Yang,Zhang Peng,Luo Yi,Lin Dong,Zhang De Chun
DOI: https://doi.org/10.1097/md.0000000000036859
IF: 1.6
2024-02-03
Medicine
Abstract:Total mesorectal excision (TME) is one of the gold standard for surgical treatment of middle and low rectal cancer, meanwhile an important protective factor for local recurrence of tumors and long-term survival of patients after surgery. [ 1 ] In recent years, laparoscopic total mesorectal excision has become the main means of clinical treatment for rectal cancer with its advantages of less trauma and quick recovery. [ 2 , 3 ] However, it is very difficult for male, obese, middle and low rectal cancer patients with large tumors after neoadjuvant treatment or pelvic stenosis, whether through minimally invasive or laparotomy TME, which tends to lead to insufficient distal margin and increased positive rate of circumferential margin. [ 4 ] In this context, some scholars believe that transanal total mesorectal excision (taTME) can overcome the technical difficulties of minimally invasive total mesorectal excision (MiTME) in some cases and improve the quality of surgical specimens due to its good "bottom-up" anatomical vision. [ 5 , 6 ] Therefore, this study aims to provide more basis for clinical treatment decisions by comparing the impact of laparoscopic total mesorectal excision (LaTME) surgery and TaTME surgery on perioperative, intestinal function, and oncology results of rectal cancer patients.
medicine, general & internal